P00747 (PLMN_HUMAN) Homo sapiens (Human)

Plasminogen UniProtKBInterProSTRINGInteractive Modelling

810 aa; Sequence (Fasta)

Sequence Features

 622Charge relay system.
 665Charge relay system.
 760Charge relay system.
 38K -> E (in PLGD; common mutation; dbSNP:rs73015965). VAR_018657 dbSNP
 46I -> R (in dbSNP:rs1049573). VAR_011779 dbSNP
 57E -> K (in dbSNP:rs4252070). VAR_016287 dbSNP
 133H -> Q (in dbSNP:rs4252186). VAR_016288 dbSNP
 147L -> P (in PLGD; dbSNP:rs770198253). VAR_018658 dbSNP
 235R -> H (in PLGD; severe type 1 deficiency; dbSNP:rs121918030). VAR_018659 dbSNP
 261R -> H (in dbSNP:rs4252187). VAR_016289 dbSNP
 374V -> F (in PLGD; Nagoya-1; dbSNP:rs121918028). VAR_006627 dbSNP
 408R -> W (in dbSNP:rs4252119). VAR_016290 dbSNP
 453K -> I (in dbSNP:rs1804181). VAR_011780 dbSNP
 472D -> N (in dbSNP:rs4252125). VAR_016291 dbSNP
 494A -> V (in dbSNP:rs4252128). VAR_016292 dbSNP
 523R -> W (in dbSNP:rs4252129). VAR_016293 dbSNP
 532R -> H (in PLGD). VAR_018660
 591S -> P (in PLGD; may be associated with susceptibility to thrombosis; dbSNP:rs121918029). VAR_006628 dbSNP
 620A -> T (in PLGD; type 2 plasminogen deficiency; decreased activity; Nagoya-2/ Tochigi/Kagoshima; may be associated with susceptibility to thrombosis; dbSNP:rs121918027). VAR_006629 dbSNP
 676V -> D (in dbSNP:rs17857492). VAR_031213 dbSNP
 751G -> R (in PLGD; Kanagawa-1; 50% activity; dbSNP:rs121918033). VAR_006630 dbSNP
 78-79Cleavage; by stromelysin-1.
 466-467Cleavage; by stromelysin-19.
 580-581Cleavage; by plasminogen activator.
 49-73
 53-61
 103-181
 124-164
 152-176
 185-262
 188-316
 206-245
 234-257
 275-352
 296-335
 324-347
 377-454
 398-437
 426-449
 481-560
 502-543
 531-555
 567-685Interchain (between A and B chains).
 577-585Interchain (between A and B chains).
 607-623
 699-766
 729-745
 756-784
 25-96PAN/Apple domain
IPR003609PF00024
 103-181Kringle
IPR000001PF00051
 185-262Kringle
IPR000001PF00051
 275-352Kringle
IPR000001PF00051
 377-454Kringle
IPR000001PF00051
 481-560Kringle
IPR000001PF00051
 581-803Serine proteases, trypsin domain
IPR001254PF00089

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRangeDownloadAssess
COMPLEX OF THE CATALYTIC DOMAIN OF HUMAN PLASMIN AND STREPTOKINASE Heteromer
P00747; P00779;
1bml561-810
CRYSTAL STRUCTURE OF MICROPLASMINOGEN-STREPTOKINASE ALPHA DOMAIN COMPLEX Heteromer
P00747; P00779;
SO4;1l4d562-810
'Structure of the ternary microplasmin-staphylokinase-microplasmin complex: a proteinase-cofactor... Heteromer
P00747; P15240;
0GJ;1bui562-810
'Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffo... Heteromer
Q4GWU5;
SO4;6d40563-810
'X-RAY CRYSTAL STRUCTURE OF THE COMPLEX OF MICROPLASMINOGEN WITH ALPHA DOMAIN OF STREPTOKINASE IN... Heteromer
P00747; P00779;
12×CD;1l4z563-810
'Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffo... Heteromer
Q4GWU5;
GOL;SO4;6d3y564-810
Crystal structure of the plasmin-textilinin-1 complex Heteromer
Q90WA1;
SO4;3uir564-810
'Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffo... Heteromer
Q4GWU5;
6d3x565-810
Protease SFTI complex Heteromer
Q4GWU5;
6d3z565-810
The X-ray crystallographic structure of the angiogenesis inhibitor, angiostatin, bound to a pepti... Heteromer
P49054;
2doi100-317
The X-ray crystallographic structure of the angiogenesis inhibitor, angiostatin, bound a to a pep... Heteromer
P49054;
DIO;2doh100-264
STRUCTURE AND BINDING DETERMINANTS OF THE RECOMBINANT KRINGLE-2 DOMAIN OF HUMAN PLASMINOGEN TO AN... Heteromer
P00747; P49054;
1i5k184-262
'Y. pestis Plasminogen Activator Pla in Complex with Human Plasminogen Activation Loop Peptide AL... Heteromer
P17811;
MRD;PO4;MPD;C8E;4dcb576-585
Human PLASMINOGEN CATALYTIC DOMAIN, K698M MUTANThomo-24-mer 192×SO4;1rjx564-810
STRUCTURE AND LIGAND DETERMINANTS OF THE RECOMBINANT KRINGLE 5 DOMAIN OF HUMAN PLASMINOGENhomo-2-mer 5hpg480-563
STRUCTURAL BASIS FOR THE CONFORMATIONAL MODULATIONmonomer SIA;GAL;NGA;CL;4a5t20-810
The X-ray Crystal Structure of Full-Length type II Human Plasminogenmonomer NAG;CL;K;SIA;GAL;ACT;BCT;4dur22-810
The X-ray Crystal Structure of Full-Length type I Human Plasminogenmonomer 4duu22-810
The X-ray Structure of Human Angiostatinmonomer BCN;1ki0100-352
Protease Inhibitormonomer 89M;5ugg563-810
Protease Inhibitormonomer 89S;5ugd563-810
CRYSTAL STRUCTURE OF HUMAN PLASMINOGEN CATALYTIC DOMAINmonomer 1ddj564-810
CATALYTIC DOMAIN OF PLASMINOGENmonomer 1qrz565-810
Solution Structure of Human Plasminogen Kringle 3monomer 2l0s272-354
Solution structure and functional characterization of human plasminogen kringle 5monomer 2knf480-562
'KRINGLE 2 DOMAIN OF HUMAN PLASMINOGEN: NMR SOLUTION STRUCTURE OF TRANS-4-AMINOMETHYLCYCLOHEXANE-...monomer AMH;1b2i181-263
plasminogen kringle 1 in complex with inhibitormonomer XO3;4cik101-181
THE STRUCTURE OF THE NON-COVALENT COMPLEX OF RECOMBINANT KRINGLE 1 DOMAIN OF HUMAN PLASMINOGEN WI...monomer ACA;1cea102-181
THE STRUCTURE OF THE NON-COVALENT COMPLEX OF RECOMBINANT KRINGLE 1 DOMAIN OF HUMAN PLASMINOGEN WI...monomer AMH;1ceb102-181
THE REFINED STRUCTURE OF THE EPSILON-AMINOCAPROIC ACID COMPLEX OF HUMAN PLASMINOGEN KRINGLEmonomer ACA;2pk4375-454
THE STRUCTURE OF RECOMBINANT PLASMINOGEN KRINGLE 1 AND THE FIBRIN BINDING SITEmonomer CL;1pkr102-181
STRUCTURE OF KRINGLE 4 AT 4C TEMPERATURE AND 1.67 ANGSTROMS RESOLUTIONmonomer SO4;1krn376-454
'CRYSTAL AND MOLECULAR STRUCTURE OF HUMAN PLASMINOGEN KRINGLE 4 REFINED AT 1.9-ANGSTROMS RESOLUTION'monomer SO4;1pk4376-454
SOLUTION NMR STRUCTURE OF THE HUMAN PLASMINOGEN KRINGLE 1 DOMAIN COMPLEXED WITH 6-AMINOHEXANOIC A...monomer 1hpj103-181
SOLUTION NMR STRUCTURE OF THE HUMAN PLASMINOGEN KRINGLE 1 DOMAIN COMPLEXED WITH 6-AMINOHEXANOIC A...monomer ACA;1hpk103-181
KRINGLE-KRINGLE INTERACTIONS IN MULTIMER KRINGLE STRUCTURESmonomer 1pmk377-454